Cochlear Needs to Keep Promoting Implants as Volume Delays Not Structural, Says Jefferies, Shares Up 4%

MT Newswires Live
Apr 30

Cochlear's (ASX:COH) current volume delays are not structural as its volume opportunity for implants remains strong, Jefferies said in a Wednesday note.

Jefferies said that US Medicare Advantage and commercial insurance providers require prior authorization for cochlear implantation procedures, which is causing delays in cochlear implant procedure volumes.

Cochlear needs to continue promoting the benefits of cochlear implants while also expanding its advocacy programs to support patient access and awareness, the investment firm added.

Jefferies kept a buy rating on Cochlear with a price target of AU$137.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10